The healthcare landscape in 2026 continues to undergo a profound transformation, characterized by a shift toward outcome-based reimbursement models, the integration of advanced artificial intelligence, and heightened public scrutiny of major insurance conglomerates. Central to this evolution is the Centers for Medicare & Medicaid Services (CMS) Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model, which has recently seen a significant expansion in its scope. During the latest episode of the Debunked Podcast, co-hosts Arundhati Parmar, editor-in-chief of MedCity News, and Samir Batra, Managing Partner of Health Innovation Pitch, explored the operational efficacy of the ACCESS Model since its July rollout. The discussion highlighted a critical juncture for the industry, with Batra famously noting that while value-based care is not dead, it is currently "in rehab," undergoing a necessary period of restructuring and refinement to overcome the complexities that hindered previous iterations of the model.
The Expansion of the CMS ACCESS Model
The CMS ACCESS Model represents a strategic pivot in how the federal government approaches chronic disease management. Originally launched to address high-prevalence conditions like hypertension and diabetes, the program was expanded in September 2026 to include heart failure, chronic obstructive pulmonary disease (COPD), substance use disorders, and tobacco cessation. This expansion acknowledges the interconnected nature of chronic illness and the high cost of acute interventions for these specific conditions. According to CMS data, chronic diseases account for approximately 90% of the $4.5 trillion in annual healthcare expenditures in the United States. By targeting these areas, the ACCESS Model seeks to reduce hospitalizations through preventive, tech-enabled care.
The model is designed to tie payments directly to patient outcomes, a departure from the traditional fee-for-service structure that often incentivized volume over quality. To achieve these outcomes, the program encourages the adoption of remote patient monitoring (RPM), digital behavioral health programs, and virtual care management teams. Batra observed that the ACCESS Model addresses a primary grievance among digital health companies: the convoluted monetary formulas that previously made participation in value-based care (VBC) programs financially precarious. By simplifying the reimbursement framework for tech-enabled interventions, CMS aims to foster a more predictable environment for innovation.
Value-Based Care: From Complexity to Rehabilitation
The assertion that value-based care is "in rehab" reflects the broader industry sentiment regarding the slow pace of VBC adoption. Despite over a decade of promotion by policymakers, many providers have struggled to move away from fee-for-service due to the administrative burden of tracking outcomes and the financial risk associated with downside-risk contracts. The "rehab" phase involves a return to basics: focusing on scalable solutions that prioritize the patient experience while ensuring that digital health providers are compensated fairly for their role in the care continuum.
Previous iterations of VBC often failed because they lacked the infrastructure to support continuous monitoring. The ACCESS Model’s reliance on technology aims to bridge this gap. For instance, in the management of COPD and heart failure, real-time data from wearable devices can alert care teams to a patient’s declining status before an emergency department visit becomes necessary. This proactive approach is the cornerstone of the "rehabbed" version of VBC, moving the industry closer to the elusive "quadruple aim" of better outcomes, lower costs, improved patient experience, and improved clinician well-being.
The Role of Artificial Intelligence and the Transparency Gap
As healthcare organizations integrate more technology to meet the requirements of the ACCESS Model, artificial intelligence (AI) has emerged as both a solution and a source of tension. The industry is currently experiencing a dichotomy in AI application. On one hand, AI tools are proving invaluable in automating labor-intensive administrative tasks, such as provider credentialing, prior authorization processing, and medical coding. These efficiencies are critical at a time when the healthcare workforce is facing significant shortages and burnout.
However, a "transparency gap" remains a significant hurdle. Healthcare providers and regulators have expressed ongoing frustration with the "black box" nature of many clinical algorithms. While tech companies promote the accuracy of their AI models in predicting patient deterioration or recommending treatment paths, the inability of these companies to explain exactly how their algorithms arrive at specific answers has led to skepticism. This lack of explainability poses risks in a value-based environment where clinical decisions directly impact reimbursement and patient safety. The demand for "Explainable AI" (XAI) is increasing, with stakeholders calling for greater clinical validation and transparency to ensure that AI-driven care does not inadvertently introduce bias or clinical errors.
Public Scrutiny and the Critique of Private Insurance
The conversation surrounding healthcare reform is not limited to regulatory models and technology; it has also permeated popular culture, reflecting a growing public dissatisfaction with the status quo of private insurance. A recent episode of "Last Week Tonight with John Oliver" brought national attention to the immense scale and influence of UnitedHealth Group (UHG) and its subsidiaries. The segment detailed how UHG, through its Optum and UnitedHealthcare arms, has become a dominant force in both the delivery and financing of care—a phenomenon known as vertical integration.
The critique focused on the administrative hurdles that many patients face, such as frequent claim denials and the complexities of prior authorization. Oliver’s segment argued that these policies often serve as barriers to care, complicating the lives of both patients and providers. For the industry, UnitedHealth Group has become a symbol of the broader systemic issues within private insurance, where the drive for profitability is often perceived as being at odds with the mission of patient care. This public scrutiny coincides with increased regulatory interest in the anti-competitive implications of vertical integration in the healthcare sector.
The Legal and Social Aftermath of the Brian Thompson Case
The tension between the public and the insurance industry reached a tragic peak in December 2024 with the murder of UnitedHealthcare CEO Brian Thompson. The case has remained a focal point of national conversation, particularly following the recent legal developments involving the suspect, Luigi Mangione. In August 2026, Mangione changed his plea to guilty, bringing a sense of closure to the criminal proceedings while simultaneously reigniting debates over the frustrations patients feel toward the insurance system.
Mangione is scheduled to be sentenced on December 18, 2026. While the act of violence was universally condemned, the social media discourse surrounding the event at the time revealed a deep-seated resentment toward the health insurance industry’s practices. This incident has forced many healthcare executives to reconsider how they communicate with the public and how they handle patient grievances. The case serves as a grim reminder of the high stakes involved in healthcare administration and the urgent need for a system that is perceived as fair, transparent, and patient-centric.
Chronology of Key Events (2024–2026)
- December 2024: UnitedHealthcare CEO Brian Thompson is fatally shot in New York City, sparking an international manhunt and a national debate on healthcare insurance practices.
- January 2025 – June 2026: CMS develops the ACCESS Model framework, focusing on simplifying reimbursement for tech-enabled chronic care management.
- July 2026: The CMS ACCESS Model is officially rolled out with an initial focus on hypertension, diabetes, and behavioral health (anxiety and depression).
- August 2026: Luigi Mangione enters a guilty plea in the murder of Brian Thompson.
- September 2026: CMS announces the expansion of the ACCESS Model to include heart failure, COPD, substance use disorders, and tobacco cessation.
- October 2026: Industry leaders discuss the "rehabilitation" of value-based care and the challenges of AI transparency on the Debunked Podcast.
- December 18, 2026: Scheduled sentencing for Luigi Mangione.
Supporting Data and Economic Impact
The shift toward the ACCESS Model and the broader adoption of value-based care is driven by staggering economic realities. According to the CDC, six in ten adults in the U.S. have a chronic disease, and four in ten have two or more. The cost of managing these conditions is the primary driver of the national debt and rising employer premiums.
Data from recent pilot programs suggests that tech-enabled care management can reduce readmission rates for heart failure patients by as much as 20% to 30%. Furthermore, digital behavioral health interventions for substance use disorders have shown a 15% increase in treatment adherence compared to traditional methods alone. These figures provide the empirical backbone for the CMS expansion and explain why the "rehab" of value-based care is receiving such significant investment.
Broader Implications and the Path Forward
The convergence of the ACCESS Model expansion, the scrutiny of insurance giants, and the evolving role of AI suggests that the healthcare industry is at a crossroads. The success of the ACCESS Model will likely depend on whether it can truly simplify the financial incentives for providers and digital health companies. If the "convoluted formulas" of the past are successfully replaced with transparent, outcome-linked payments, the industry may finally see the widespread adoption of VBC that has been promised for decades.
However, the industry must also address the trust deficit. Whether it is the lack of transparency in AI algorithms or the public outcry over insurance denials, the "human" element of healthcare cannot be ignored. The "rehab" of value-based care must include a focus on rebuilding trust between patients, providers, and payers. As the sentencing of Luigi Mangione approaches and the ACCESS Model enters its next phase, the healthcare sector remains under a microscope, tasked with proving that it can innovate while remaining compassionate and accountable to the populations it serves.
